Novo Nordisk A/S (NVO)

About Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

As of November 3, 2026, Novo Nordisk A/S (NVO) stock is trading at $40.45, roughly flat versus the previous close. On the day, shares have traded between $40.17 and $40.53. That puts NVO in the lower third of its 52-week range of $35.12 to $64.16. Novo Nordisk A/S carries a market capitalization of roughly $176.43 billion, with about 1.49 million shares changing hands.

Latest NVO news

• Novo Nordisk A/S - share repurchase programmeYahoo Finance· Nov 3, 9:51 AM ETMAR
• MitoRx Therapeutics Appoints Neil Anderson as Chief Business OfficerYahoo Finance· Nov 3, 7:00 AM ET
• LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?Yahoo Finance· Nov 3, 6:11 AM ET
• Novo Nordisk (CPSE:NOVO B) Set To Unveil New Obesity Data At ObesityWeek 2026Yahoo Finance· Nov 2, 8:23 PM ET
• Earnings live updates: Roku posts earnings beat ahead of acquisition by FoxYahoo Finance· Nov 2, 4:28 PM ET
• Musk Predicts “Banger Drugs Coming Out” from Eli Lillytikr.com· Nov 2, 12:11 PM ET
• Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?Yahoo Finance· Nov 2, 11:22 AM ET
• Here's Why I Think Every Investor Needs to Invest in These "Miracle" Drugsfool.com· Nov 2, 9:20 AM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want NVO headlines, alerts and AI research in one place? Create a free account →

• $NVO cmon you little slut.

  @Hooooooold· Nov 3, 9:39 AM ET

• $VKTX $NVO earnings tomorrow am 🤔🤫

  @optn_trader· Nov 3, 9:37 AM ET

• $NVO Lilly is worth $1.1 Trillion more than Novo?!?! Make this make sense.

  @mrkymrk· Nov 3, 9:37 AM ET

• 🚨🌍 $NVO – WEGOVY PILL GLOBAL EXPANSION IS ACCELERATING! Novo Nordisk is expanding oral Wegovy into new international markets, creating additional growth opportunities beyond the US. 💊 Recent launches: 🇺🇸 USA – January 5 🇦🇪 UAE – June 3 🇬🇧 UK – July 🇩🇪 Germany – Sept…

  @pe_to· Nov 3, 8:16 AM ET· Bullish

• $NVO expecting a 20% haircut after earnings are announced. Nothing in the pipeline to attract buyers.

  @Bagman25· Nov 3, 7:50 AM ET· Bearish

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →